Paloma Health Technologies Paloma TalentPaloma Cares

Accreditation & Surveys Other CMS-approved accreditors

Accreditation guide

Other CMS-approved accreditors

Beyond the three home-care accreditors, CMS approves pharmacy-centred and DMEPOS accreditors. None of these holds Medicare home health or hospice deeming.

Educational summary, last reviewed October 17, 2026. Not legal advice — confirm with the state licensing agency or counsel.

Last reviewed October 17, 2026. 5 findings: 5 verified. How findings are sourced and labelled.

1Scope by program

CMS approval terms by accrediting organization
AccreditorMedicare home healthMedicare hospiceHome infusion therapy supplierDMEPOS
The Joint CommissionMarch 31, 2026 – March 31, 2032 sourceJune 18, 2025 – June 18, 2030 sourceDecember 15, 2023 – December 15, 2029 sourceApproved source
CHAPMarch 31, 2024 – March 31, 2030 sourceNovember 20, 2024 – November 20, 2029 sourceSeptember 25, 2024 – September 25, 2030 sourceApproved source
ACHCFebruary 24, 2025 – February 24, 2031 sourceNovember 27, 2025 – November 27, 2031 sourceApril 23, 2024 – April 23, 2030 sourceApproved source
URACNoNoMarch 27, 2024 – March 27, 2030No
NABPNoNoSeptember 26, 2024 – September 26, 2030Approved
The Compliance TeamNoNoSeptember 28, 2024 – September 28, 2030Approved
HQAA, ABC, BOCNoNoNoApproved

“No” means the organization holds no CMS approval for that program in the sources reviewed. Non-deemed programs (private duty and personal care, pharmacy, palliative care, ambulatory infusion centers) have no Medicare certification behind them.

URAC

Verified

Approved for home infusion therapy suppliers, March 27, 2024 to March 27, 2030; not on the DMEPOS list.

Source: Federal Register 2024-06144CMS: DMEPOS accreditation organizations (updated January 9, 2026)

Last verified October 17, 2026

NABP

Verified

Approved for home infusion therapy suppliers, September 26, 2024 to September 26, 2030, and on the DMEPOS list.

Source: Federal Register 2024-21409CMS: DMEPOS accreditation organizations (updated January 9, 2026)

Last verified October 17, 2026

Approved for home infusion therapy suppliers, September 28, 2024 to September 28, 2030, and on the DMEPOS list.

Source: Federal Register 2024-21410CMS: DMEPOS accreditation organizations (updated January 9, 2026)

Last verified October 17, 2026

On CMS’s DMEPOS list only. BOC (Board of Certification/Accreditation) is a DMEPOS accreditor, not a home infusion therapy accreditor.

Source: CMS: DMEPOS accreditation organizations (updated January 9, 2026)CMS Manual Transmittal r10467pi (HIT accreditors)

Last verified October 17, 2026

From January 1, 2026, DMEPOS suppliers are surveyed and reaccredited at least every 12 months, replacing a three-year cycle; every supplier location is accredited separately (42 CFR 424.57(c)(24)). The phase-in timing was not confirmed.

Source: Federal Register 2025-21767 (CY 2026 HH PPS final rule)

Last verified October 17, 2026 · Effective January 1, 2026

Official sources

Revision history

DateChange
2026-10-17First published

About this guide. Published and maintained by Paloma Health Technologies; Findings are cited to official sources, dated and status-labelled; see the editorial policy. Educational summary, last reviewed October 17, 2026. Not legal advice — confirm with the state licensing agency or counsel.

Questions

Other CMS-approved accreditors: common questions

Can URAC accredit a Medicare home health agency?

No. URAC holds CMS approval for home infusion therapy suppliers only, among these programs.